Yanan Zhao

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Left Ventricular

Chronic Lymphocytic Leukemia

Top Venues

Journal of the American Heart Association

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yanan Zhao, Praloy Chakraborty, Julianna Tomassetti, Tasnia Subha, Stephane Masse, Paaladinesh Thavendiranathan, Filio Billia, Patrick F H Lai, Husam Abdel-Qadir, Kumaraswamy Nanthakumar
Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib. International journal of molecular sciences 25 (11) (2024)
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan C Denham, Stephane Masse, Patrick F H Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel-Qadir, Gary D Lopaschuk, Kumaraswamy Nanthakumar
Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca 2+ -Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability. Journal of the American Heart Association (2024)
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan C Denham, Stephane Masse, Patrick F H Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel-Qadir, Gary D Lopaschuk, Kumaraswamy Nanthakumar
Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca 2+ -Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability. Journal of the American Heart Association 13 (12) (2024)
Yanan Zhao, Praloy Chakraborty, Julianna Tomassetti, Tasnia Subha, Stephane Masse, Paaladinesh Thavendiranathan, Filio Billia, Patrick F H Lai, Husam Abdel-Qadir, Kumaraswamy Nanthakumar
Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib. International journal of molecular sciences 25 (11) (2024)
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan C Denham, Stephane Masse, Patrick F H Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel-Qadir, Gary D Lopaschuk, Kumaraswamy Nanthakumar
Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca 2+ -Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability. Journal of the American Heart Association 13 (12) (2024)
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan C Denham, Stephane Masse, Patrick F H Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel-Qadir, Gary D Lopaschuk, Kumaraswamy Nanthakumar
Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca 2+ -Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability. Journal of the American Heart Association 13 (12) (2024)
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan C Denham, Stephane Masse, Patrick F H Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel-Qadir, Gary D Lopaschuk, Kumaraswamy Nanthakumar
Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca 2+ -Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability. Journal of the American Heart Association 13 (12) (2024)
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan C Denham, Stephane Masse, Patrick F H Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel-Qadir, Gary D Lopaschuk, Kumaraswamy Nanthakumar
Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca 2+ -Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability. Journal of the American Heart Association 13 (12) (2024)